Polymyxin B Inj Generic Name & Formulations
Legal Class
Rx
General Description
Polymyxin B sulfate 500,000units/vial; pwd for IM, intrathecal inj, IV drip or ophthalmic use after reconstitution.
Pharmacological Class
Antibiotic.
How Supplied
Contact supplier.
Manufacturer
Polymyxin B Inj Indications
Indications
Susceptible infections due to P. aeruginosa including UTIs, meninges, bloodstream, and eye infections. Other serious susceptible infections including H. influenza meningeal, E. coli UTIs, and bacteremia due to A. aerogenes and K. pneumoniae.
Polymyxin B Inj Dosage and Administration
Adults and Children
Infants: up to 40,000units/kg per day IV or IM inj. Adults and children: IV: 15,000–25,000units/kg per day in divided doses every 12 hours; max 25,000units/kg per day. IM: 25,000–30,000units/kg per day in divided doses every 4–6 hours. P. aeruginosa meningitis: Give by intrathecal inj only. <2yrs: 20,000units once daily for 3–4 days or 25,000units once every other day, continue with 25,000units once every other day; >2yrs: 50,000units once daily for 3–4 days, then 50,000units once every other day; both: treat for at least 2 weeks after negative CSF cultures and sugar content normalized. Ophthalmic: see literature. Renal impairment: adjust or reduce dose.
Polymyxin B Inj Contraindications
Not Applicable
Polymyxin B Inj Boxed Warnings
Not Applicable
Polymyxin B Inj Warnings/Precautions
Warnings/Precautions
Renal impairment. Monitor renal function before and during therapy; discontinue if nephrotoxicity occurs. Pregnancy: not recommended.
Polymyxin B Inj Pharmacokinetics
See Literature
Polymyxin B Inj Interactions
Interactions
Avoid other neurotoxic and/or nephrotoxic drugs (eg, bacitracin, aminoglycosides, colistin). May potentiate neuromuscular blockade with anesthetics and/or muscle relaxants.
Polymyxin B Inj Adverse Reactions
Adverse Reactions
Nephrotoxicity (eg, albuminuria, azotemia, cylindruria), neurotoxicity (eg, flushing, dizziness, paresthesias), meningeal irritation (intrathecal), drug fever, rash, inj site pain, thrombophlebitis; respiratory paralysis (discontinue if occurs).
Polymyxin B Inj Clinical Trials
See Literature
Polymyxin B Inj Note
Notes
Formerly known under the brand name Aerosporin.
Polymyxin B Inj Patient Counseling
See Literature